These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26995415)

  • 21. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
    Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
    Hasegawa T; Ako J; Koo BK; Miyazawa A; Sakurai R; Chang H; Dens J; Verheye S; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):34-41. PubMed ID: 19089934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study.
    Sarno G; Garg S; Gomez-Lara J; Garcia Garcia HM; Ligthart J; Bruining N; Onuma Y; Witberg K; van Geuns RJ; de Boer S; Wykrzykowska J; Schultz C; Duckers HJ; Regar E; de Jaegere P; de Feyter P; van Es GA; Boersma E; van der Giessen W; Serruys PW;
    EuroIntervention; 2011 Mar; 6(8):977-84. PubMed ID: 21330246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guide-catheter extension system facilitated multiple bioresorbable vascular scaffolds (ABSORB®) delivery in a very long and resistant coronary artery lesion.
    Ielasi A; Anzuini A
    Cardiovasc Revasc Med; 2014 Mar; 15(2):117-20. PubMed ID: 24054502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of dissection due to residual dissection after intracoronary stenting for spontaneous coronary dissection at bifurcation site of LAD and diagonal artery.
    Kang WC; Oh KJ; Han SH; Ahn TH; Shin EK
    Int J Cardiol; 2008 Apr; 125(3):e40-3. PubMed ID: 17397947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standardized angiographically guided over-dilatation of stents using high pressure technique optimize results without increasing risks.
    Johansson B; Allared M; Borgencrantz B; Brorson L; Geijer Hk; Kellerth T; Olsson H; Ragnarsson A; Skoglund H; Wennerblom B
    J Invasive Cardiol; 2002 May; 14(5):221-6. PubMed ID: 11983940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary stenting with cardiogenic shock due to acute ascending aortic dissection.
    Hanaki Y; Yumoto K; I S; Aoki H; Fukuzawa T; Watanabe T; Kato K
    World J Cardiol; 2015 Feb; 7(2):104-10. PubMed ID: 25717358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of a scoring balloon for optimal lesion preparation prior to bioresorbable scaffold implantation: a comparison with conventional balloon predilatation.
    Miyazaki T; Latib A; Ruparelia N; Kawamoto H; Sato K; Figini F; Colombo A
    EuroIntervention; 2016 Apr; 11(14):e1580-8. PubMed ID: 27056118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Everolimus-eluting Bioresorbable Vascular Scaffold Implantation in Real World and Complex Coronary Disease: Procedural and 30-day Outcomes at Two Australian Centres.
    Robaei D; Back LM; Ooi SY; Pitney MR; Jepson N
    Heart Lung Circ; 2015 Sep; 24(9):854-9. PubMed ID: 25778622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial.
    Diletti R; Farooq V; Girasis C; Bourantas C; Onuma Y; Heo JH; Gogas BD; van Geuns RJ; Regar E; de Bruyne B; Dudek D; Thuesen L; Chevalier B; McClean D; Windecker S; Whitbourn RJ; Smits P; Koolen J; Meredith I; Li X; Miquel-Hebert K; Veldhof S; Garcia-Garcia HM; Ormiston JA; Serruys PW
    Heart; 2013 Jan; 99(2):98-105. PubMed ID: 23118346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials.
    Brugaletta S; Gomez-Lara J; Diletti R; Farooq V; van Geuns RJ; de Bruyne B; Dudek D; Garcia-Garcia HM; Ormiston JA; Serruys PW
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):219-28. PubMed ID: 21563288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated disease of the ostium left anterior descending or circumflex artery: management using a left main stenting technique. Clinical outcome at 2 years.
    Cubeddu RJ; Wood FO; Saylors EK; Mann T
    J Invasive Cardiol; 2007 Nov; 19(11):457-61. PubMed ID: 17986719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH).
    Simsek C; Magro M; Onuma Y; Boersma E; Smits P; Dorange C; Veldhof S; Regar E; Serruys PW; van Geuns RJ
    EuroIntervention; 2014 Jun; 10(2):236-40. PubMed ID: 23999210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Provisional hybrid 2-stent Strategy utilizing bioresorbable vascular scaffold and drug-eluting metal stent: "T-stenting and small protrusion" technique.
    Miyazaki T; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):682-5. PubMed ID: 25510349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
    Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ;
    JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multislice CT for assessing in-stent dimensions after left main coronary artery stenting: a comparison with three dimensional intravascular ultrasound.
    Roura G; Gomez-Lara J; Ferreiro JL; Gomez-Hospital JA; Romaguera R; Teruel LM; Carreño E; Esplugas E; Alfonso F; Cequier A
    Heart; 2013 Aug; 99(15):1106-12. PubMed ID: 23723447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravascular ultrasound-based left main coronary artery assessment: comparison between pullback from left anterior descending and circumflex arteries.
    Suter Y; Schoenenberger AW; Toggweiler S; Jamshidi P; Resink T; Erne P
    J Invasive Cardiol; 2009 Sep; 21(9):457-60. PubMed ID: 19726818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in left main bifurcation geometry after a single-stent crossover technique: an intravascular ultrasound study using direct imaging of both the left anterior descending and the left circumflex coronary arteries before and after intervention.
    Kang SJ; Mintz GS; Kim WJ; Lee JY; Oh JH; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Circ Cardiovasc Interv; 2011 Aug; 4(4):355-61. PubMed ID: 21712525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.